IRIS
LUNGHI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.601
AS - Asia 6.408
EU - Europa 5.076
SA - Sud America 809
AF - Africa 299
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 7
Totale 19.217
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.387
SG - Singapore 2.598
CN - Cina 2.215
IE - Irlanda 891
FI - Finlandia 883
IT - Italia 729
DE - Germania 724
SE - Svezia 713
BR - Brasile 658
HK - Hong Kong 500
UA - Ucraina 474
VN - Vietnam 373
TR - Turchia 320
NL - Olanda 238
ZA - Sudafrica 198
CA - Canada 151
GB - Regno Unito 130
IN - India 127
RU - Federazione Russa 62
AR - Argentina 56
FR - Francia 50
CI - Costa d'Avorio 46
BD - Bangladesh 45
JP - Giappone 43
MX - Messico 35
AT - Austria 33
PL - Polonia 30
IQ - Iraq 26
EC - Ecuador 25
ID - Indonesia 23
BE - Belgio 21
KR - Corea 21
RO - Romania 20
ES - Italia 18
PK - Pakistan 17
EU - Europa 16
IR - Iran 16
VE - Venezuela 14
CZ - Repubblica Ceca 13
LT - Lituania 13
MA - Marocco 13
CL - Cile 12
CO - Colombia 12
JO - Giordania 12
PY - Paraguay 12
UZ - Uzbekistan 11
DZ - Algeria 10
EG - Egitto 10
SA - Arabia Saudita 10
UY - Uruguay 10
DO - Repubblica Dominicana 8
AE - Emirati Arabi Uniti 6
NP - Nepal 6
TN - Tunisia 6
AZ - Azerbaigian 5
BO - Bolivia 5
CH - Svizzera 5
CR - Costa Rica 5
KE - Kenya 5
PE - Perù 5
AU - Australia 4
IL - Israele 4
JM - Giamaica 4
TW - Taiwan 4
BH - Bahrain 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
GA - Gabon 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 19.210
Salva come PNG Salva come JPEG
Città #
Singapore 1.243
Dublin 892
Jacksonville 726
Chandler 674
Ashburn 597
Beijing 585
Hong Kong 496
Dearborn 394
Santa Clara 390
Dallas 300
Boardman 283
Nanjing 278
Izmir 275
San Mateo 239
Ann Arbor 217
Princeton 203
Johannesburg 190
Munich 167
Wilmington 150
Parma 147
Ho Chi Minh City 134
Helsinki 130
Los Angeles 114
Shenyang 112
Toronto 108
Hefei 101
Shanghai 89
Jinan 85
Kunming 85
Nanchang 83
New York 77
Hebei 74
Hanoi 72
São Paulo 59
Changsha 55
Tianjin 52
Jiaxing 50
Düsseldorf 49
Abidjan 46
Grafing 46
Woodbridge 45
Seattle 43
Bologna 42
Buffalo 41
Tokyo 41
Guangzhou 38
Milan 36
Columbus 35
Moscow 35
Rio de Janeiro 32
Zhengzhou 32
Turku 31
Des Moines 30
Kocaeli 29
Norwalk 28
Pune 28
Warsaw 28
Haiphong 27
Houston 27
Hangzhou 24
London 23
Brussels 21
Fremont 21
Leawood 21
Rome 21
Atlanta 20
Bremen 20
Brooklyn 19
Chennai 19
Lanzhou 19
Montreal 19
Nuremberg 19
Augusta 18
Ningbo 18
Stockholm 18
Taizhou 18
Haikou 17
Phoenix 17
Belo Horizonte 16
Falls Church 16
Seoul 16
Bengaluru 15
Poplar 15
San Francisco 15
The Dalles 15
Vienna 15
Boston 14
Council Bluffs 14
Fuzhou 14
Mexico City 14
Modena 14
Campinas 13
Denver 13
Amman 12
Curitiba 12
Hải Dương 12
Mumbai 12
San Jose 12
Jakarta 11
Marseille 11
Totale 11.388
Salva come PNG Salva come JPEG
Nome #
2,6-Diacetylpyridine bis(thiosemicarbazones) zinc complexes: synthesis, structure, and biological activity 289
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 281
Endocanalicular transendothelial crossing (ETC): A novel intravasation mode used by HEK-EBNA293-VEGF-D cells during the metastatic process in a xenograft model 238
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 216
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 211
The Pharmacological Blockade of Phosphodiesterase IV Potentiates the Anti-Tumor Effects of Arsenic Trioxide (ATO) in Acute Myelogenous Leukemia Cells through Multiple Signaling Pathways 201
Acenaphthenequinone Thiosemicarbazone and Its Transition Metal Complexes: Synthesis, Structure, and Biological Activity 187
Attività biologica del tiosemicarbazone del piridossale e dei suoi complessi di rame 169
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 162
L'attività della wortmannin inibitore della fosfatidilinositolo-3 chinasi su cellule di leucemia mieloide cronica in fase cronica 150
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 149
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 148
Air purification and indoor biologic pollutants 145
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 145
Alpha and Gamma interferons do not modulate the levels of JNK/SAPK activation in Ph+ leukemic cell lines 143
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 139
A translational perspective of the malignant hematopoietic proteoglycome 137
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 137
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 136
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 135
: Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 134
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. 132
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 130
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure and biological activity 129
Fosforilazione in tirosina delle proteine adattatrici SHC ed attivazione di ERK-JNK/SAPK kinasi in leucemia acuta mieloblastica 127
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 125
Acenapthenequinone thiosemicarbazone and its transition metal complexes. Synthesis, structure and biological activity 125
Analisi dei meccanismi di attivazione di SHC, ERK e JNK in leucemia acuta mieloide 124
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 121
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 121
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 120
L'inibizione della proliferazione indotta dal tiosemicarbazone della 2-piridina carbossialdeide e dai relativi complessi di stagno in linee cellulari umane e in cellule derivate da pazienti leucemici è associata ad apotosi 119
An abatement of the concentration of mycophytes, dust mites and pollen grains in the indoor environment using an air purifier 118
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 116
Emerging MEK inhibitors 116
Treatment with Arsenic Trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 115
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 115
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells 115
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 113
Transition-Metal Complexes of Isatin-beta-Thiosemicarbazone. X-Ray Crystal Structure of Two Nickel Complexes 113
Emerging Raf inhibitors 112
Down-Modulation of Erk Protein Kinase Activity Inhibits Vascular Endothelial Growth Factor (VEGF) Secretion by human Myeloma Cell Lines 111
An abatement of the concentration of mycophytes, dust mites and pollens grains in the indoor environment using an air purifier 109
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 107
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 106
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. 106
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 106
Tyrosine-phosphorylation of SHC adaptor proteins and activation of ERK-JNK/SAPK MAP kinases in acute myelogenous leukemia 106
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 105
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 105
p73 and p53 pathway in human breast cancers. 105
The ontogenesis of BCL2 oncogen protein in human hemopoietic development 103
2,6-Diacetylpyridine Bis(Thiosemicarbazones) Zinc Complexes: Synthesis, Structure, and Biological Activity 102
Arsenic trioxide in hematological malignancies: The new discovery of an ancient drug 102
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 102
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 102
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 102
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 101
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 98
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. 97
High levels of ERK constitutive activity in acute myelogenous leukemia 97
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 97
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 97
Le IgG normali e quelle di soggetti con lupus eritematoso sistemico esercitano un effetto pro-infiammatorio precoce su cellule tubulari umane 96
Tyrosine phosphorylation of SHC adaptor proteins in chronic myelogenous leukemia 96
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors 96
High levels of p52/p46 SHC tyrosine-phosphorylation in CD34+ acute myelogenous leukemia 95
Resistance of multiple myeloma cells to trail is overcome by blockade of aurora kinases 94
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting 93
Riduzione di allergeni indoor con purificatore d’aria 92
Attività biologica dei tiosemicarbazoni dell'acido alfa-chetoglutarico e della 2,6 diacetilpiridina 92
Selective inhibition of MEK1 kinase down-modulates ERK activity and proliferation of acute myeloid leukemia blasts 92
Riduzione della concentrazione di micofiti, pollini e allergeni della polvere in ambienti confinati 92
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 92
Synthesis, characterization, X-ray strucrure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 92
Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones 91
The reduction of the concentration of dust mites, mycophites and pollen grains in the indoor environment by means of an air purifier 91
An abatment of the concentration of mycophytes and pollen grains in the indoor environment using an air purifier 91
Acetylation of core histone tails in cord blood hematopoietic progenitors 91
Analisi della chinasi ERK in leucemia acuta mieloblastica e malattie linfoproliferative croniche 90
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. 90
Selective inhibition of MEK1 kinase downmodulates ERK activity and proliferation of acute myeloid leukemia blasts 89
Attivazione costitutiva di ERK in leucemia acuta mieloblastica 89
High levels of ERK constitutive activity in acute myelogenous leukemia 89
Espressione dell'oncogene BCL2 in cellule emopoietiche fetali umane 89
Hypoxia and Hypoxia Inducible Factor (HIF)-1α in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment. 88
Constitutive expression and tyrosine phosphorylation of SHC proteins in chronic myelogenous leukemia 88
Chimica, struttura ed attività biologica di sistemi metallo-legante solforato 88
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 87
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands. 87
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent antitumor activity in NOD-SCID mice bearing advanced tumors of human multiple myeloma. 87
Ontogenesis of signalling proteins:SHC, ERK, JNK expression and phosphorylation during human heart developpement 87
High levels of P52/p46 SHC tyrosine-phosphorylation in CD34+ acute myelogenous leukemia 86
Betulaceae, Corylaceae, Cupressaceae, Fagaceae and Salicaceae around Parma (Northern Italy): pollen calendars from 1995 to 1997 86
Studio della trasduzione del segnale di attivazione cellulare attraverso l'espressione e la fosforilazione di SHC ed ERC chinasi 86
Riduzione della carica batterica aerodispersa mediante utilizzo di un purificatore d'aria in ambienti indoor 86
Blockade of Aurora kinases activity enhances APO2L/TRAIL sensitivity in multiple myeloma 85
Ontogenesi dell'oncogene BCL2 in tessuti emopoietici fetali 85
L'inibizione selettiva della chinasi ERK controlla la proliferazione dei blasti di leucemia mieloide acuta 85
Selective inhibition of MEK! Kinase downmodulates ERK activity and prolifaretion of acute myeloid leukemia blasts 85
Totale 11.642
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.315
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021831 0 0 0 0 0 35 106 14 335 53 256 32
2021/2022980 18 13 8 26 22 54 110 171 52 122 108 276
2022/20232.981 398 260 181 182 249 310 17 187 1.095 12 79 11
2023/20241.076 77 94 32 31 108 225 85 51 26 72 115 160
2024/20253.883 98 249 257 205 408 311 139 136 609 364 312 795
2025/20264.411 755 732 914 643 1.052 315 0 0 0 0 0 0
Totale 19.297